Phase 1 Dosing Study of BAX 513 in Healthy Volunteers

Update Il y a 4 ans
Reference: NCT01063101

Woman and Man

  • | Country :
  • Austria
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The purpose of the study is to investigate whether orally administered BAX 513 (different doses administered for 5 days) affects hemostatic parameters in healthy volunteers.


Inclusion criteria

  • Not Applicable (Healthy Volunteers)

Links